Влияние миметика фактора роста нервов ГК-2 на структурно-функциональное состояние мозга в раннем постреанимационном периоде (экспериментальное исследование)

Objective: to evaluate the efficacy of the nerve growth factor mimetic GK-2 used to improve the structural and functional state of the brain in the early postresuscitation period. Material and methods. Cardiac arrest was induced in mature male albino rats for 12 minutes, followed by resuscitation. The neurological state of the resuscitated animals was assessed by a scoring scale. On postresuscitation day 7, the density and composition of neuronal populations of Purkinje cells in the lateral cerebellar region and pyramidal neurons in the hippocampal CA1 sector were determined by a differential morphometric analysis. The results were statistically processed using the ANOVA method. Results. The use of GK-2 was found to accelerate neurological recovery in the resuscitated animals. On day 7 after 12-minute cardiac arrest, the resuscitated animals showed neuronal dystrophic changes and death in the neuronal populations highly susceptible to ischemia. It was shown that the systemic administration of the nerve growth factor mimetic GK-2 contributed to a reduction in the magnitude and depth of postresuscitation changes in the cerebellar Purkinje cells and prevented dystrophic changes in the pyramidal cells of the hippocampal CA1 sector. The findings suggest that GK-2 has a neuroprotective effect in the recovery period after total body ischemia. Conclusion. The results of this study indicate the efficiency of the systemic administration of the nerve growth factor mimetic GK-2 in improving the brain structural and functional state in the early postresuscitation period. This determines perspectives for the use of GK-2 to prevent and correct posthypoxic encephalopathies. Key words: the nerve growth factor mimetic GK-2, postresuscitation period, neuronal dystrophic changes and death, neurological status.

• Publication year

  2012

• Venue

  General Reanimatology

• Publication date

  2012-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.15360/1813-9779-2012-5-19
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia

  2011cited by this paper
• [Protective effects of nerve growth factor vs Danshen on hippocampal neuron against global ischemia-reperfusion injury in gerbils].

  2011cited by this paper
• Взаимосвязь уровня экспрессии белка GRP78 с выраженностью постишемического повреждения гиппокампа у крыс разного пола

  2011cited by this paper
• Target Identification for CNS Diseases by Transcriptional Profiling

  2009cited by this paper
• Neuroprotection in experimental stroke with targeted neurotrophins

  2005cited by this paper
• Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

  2002cited by this paper
• Development of pharmacological agents for targeting neurotrophins and their receptors.

  2000cited by this paper

• Prognostic Value and Therapeutic Potential of Brain-Derived Neurotrophic Factor (BDNF) in Brain Injuries (Review)

  2019cites this paper
• Significance of Basic Fibroblast Growth Factor ( BFGF ) in The Development of Postresuscitation Changes in Population of Cerebellar Purkinje Cells

  2016cites this paper
• Effectiveness of GK-2, a Nerve Growth Factor Mimetic, in Preventing Post-Resuscitation Changes in the Brain

  2015cites this paper
• [The development of a pharmacologically active low-molecular mimetic of the nerve growth factor].

  2015cites this paper
• [The development of a pharmacologically active low-molecular mimetic of the nerve growth factor].

  2015cites this paper
• New Aspects of Resuscitation in Neurology and Neurosurgery

  2015cites this paper